ArticleEvidence-based complementary and alternative medicine : eCAM2022

GOLM1 as a Potential Therapeutic Target Modulates B7-H3 Secretion to Drive Ovarian Cancer Metastasis.

Junhua Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.